Prostaglandin-e2 is a potent inhibitor of human interleukin 12 production

Journal of Experimental Medicine

Volumn 181, Issue 2, 1995, Pages 775-779

  van der Pouw Kraan, Tineke C T M ^a   Boeije, Leonie C M ^a   Smeenk, Ruud J T ^a   Wijdenes, John ^a,b   Aarden, Lucien A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Innotherapie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC AMP; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; PROSTAGLANDIN E2;

ALLERGIC REACTION; ANTIGEN PRESENTING CELL; ARTICLE; DELAYED HYPERSENSITIVITY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE;

CYCLIC AMP; DINOPROSTONE; HUMAN; IN VITRO; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; SUPPORT, NON-U.S. GOV'T;

EID: 0028936406     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.2.775     Document Type: Article

References (33)

1. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
2. Romagnani, S. 1991. Human Thl and Th2 subsets: doubt no more. Immunol. Today. 12: 256-257.
3. Hsieh, C.S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O’Carra, and K.M. Murphy. 1993. Development of Thl CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260: 547-549.
4. Heinzel, F.P., D.S. Schoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp Med. 177: 1505-1509.
5. Sypek, J.P., C.L. Chung, S.E.H. Mayor, J.F. Subramanyam, S.J. Goldman, D. Sieburth, S.F. Wolf, and R.G. Schaub. 1993. Resolution of cutaneous Leishmaniasis: interleukin 12 initiates a protective T helper 1 immune response. J. Exp Med. 177: 1797-1802.
6. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Thl cells. Immunol Today. 14: 335-338.
7. Manetti, R., P. Parronchi, M.G. Giudizi, M.P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer stimulatory factor (interleukin 12 [IL-12]) induces T helper 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp Med. 177: 1199-1204.
8. McKnight, A.J., G.J. Zimmer, I. Fogelman, S.F. Wolf, and A.K. Abbas. 1994. Effects of IL-12 on helper T cell-development immune responses in vivo. J. Immunol 152: 2172-2179.
9. Seder, R.A., R. Gazzinelli, A. Sher, and W.E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon-gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90: 10188-10192.
10. Gately, M.K., B.B. Desai, A.G. Wolitzki, P.M. Quinn, C.M. Dwyer, F.J. Podlaski, P.C. Familletti, F. Sinigaglia, R. Chizonnite, U. Gubler, and A.S. Stern. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol 147: 874-882.
11. Wolf, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol 146: 3074-3081.
12. D’Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S.F. Wolf, and G, Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp Med. 176: 1387-1398.
13. D’Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-y production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cels. J. Exp. Med. 178: 1041-1048.
14. Gazzinelli, R.T., S. Hieny, T.A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90: 6115-6119.
15. Phipps, R.P., S.H. Stein, and R.L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today. 12: 349-352.
16. van der Pouw Kraan, T., C. Van Kooten, H.J.A.M. Rensink, and L.A. Aarden. 1992. IL-4 production by human T cells. Differential regulation of IL-4 versus IL-2 production. Eur. J. Immunol. 22: 1237-1241.
17. Snijdewint, F.G.M., P. Kalinski, E.A. Wierenga, J.D. Bos, and M. L. Kapsenberg. 1993. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150: 5321-5329.
18. Betz, M., and B.S. Fox. 1991. Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines.J. Immunol. 146: 108-113.
19. Novak, T.J., and E.V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA. 87: 9353-9357.
20. Munoz, E., A.M. Zubiaga, M. Merrow, N.P. Sauter, and B. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp Med. 172: 95-103.
21. Gajewski, T.F., S.R. Schell, and F.W. Fitch. 1990. Evidence implicating utilization of different T cell receptor-associated signaling pathways by T"1 and T"2 clones. J. Immunol. 144: 4110-4120.
22. Schindler, R., and C.A. Dinarello. 1989. A method for removing interleukin-1-and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysul-fone. J. Immunol. Methods. 116: 159-165.
23. Aarden, L.A., E.R. De Groot, O.L. Schaap, and P.M. Lans-dorp. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17: 1411-1416.
24. Kammer, G.M. 1988. The adenylate cyclase-cAMP-protein kinase: a pathway and regulation of the immune response. Immunol. Today. 9: 222-229.
25. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91: 759-765.
26. Meyaard, L., H. Schuitemaker, and F. Miedema. 1993. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function. Immunol. Today. 14: 161-164.
27. Chemini, J., S.E. Starr, I. Frank, A. D’Andrea, X. Ma, R.R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp Med. 179: 1361-1366.
28. Foley, P., F. Kazazi, R. Biti, T.C. Sorrell, and A.L. Cunningham. 1992. HIV infection of monocytes inhibits the T-lympho-cyte proliferative response to recall antigens, via production of eicosanoids. Immunology. 75: 391-397.
29. Mastino, A., S. Grelli, M. Piacentini, S. Oliverio, C. Favalli, C.F. Perno, and E. Garaci. 1993. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell. Immunol. 152: 120-130.
30. Hoffmann, B., P. Nishanian, T. Nguyen, M. Liu, and J.L. Fahey. 1993. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS (Phila.). 7: 659-664.
31. Jacob, T., B.N. Huspith, Y.E. Latchman, R. Rycroft, and J. Brostoff. 1990. Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin. Exp Immunol. 79: 380-384.
32. Leung, D.Y.M., L. Key, J.J. Steinberg, M.C. Young, M. Von Deck, R. Wilkinson, and R.S. Geha. 1988. Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immunol 140: 84-88.
33. van der Pouw Kraan, T., R. De Jong, and L.A. Aarden. 1993. Development of human Thl and Th2 cytokine responses. The cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur. J. Immunol. 23: 1-5.